Monthly Investor Bulletin
When: Wednesday, May 10, 2017 at 10:15
Where:The Intercontinental Barclay New York
Grand Ballroom & Empire Ballroom
111 East 48th Street
New York, NY 10017
In collaboration with Bodhi R&D, Konkussion is conducting a research trial into the use of cannabis in the treatment of concussions and post-concussive syndrome, under the direction of Dr. [...]
Value weed investors have been licking their lips as the stock price of CannaRoyalty (CRZ.C) has taken a slow rolldown over the last few weeks.
CannaRoyalty Corp. (CSE: CRZ) (OTCQX: CNNRF) (“CannaRoyalty” or the “Company”) announces the Company has begun trading today on the OTCQX® Best Market, under the symbol “CNNRF,” upgrading to [...]
CannaInsider interviews CEO Marc Lustig
Back in December, Benzinga and Viridian Capital Advisors president Scott Greiper and vice president Harrison Phillips discussed the possibility of the firm launching a cannabis-focused ETF.
CannaRoyalty Corp. (CSE: CRZ) (OTCQB: CNNRF) (“CannaRoyalty” or the “Company”) announced the launch of “The Terpistry” in collaboration with Dr. Jörg Bohlmann, a world recognized leader in [...]
Equity Guru features CannaRoyalty
We provide investors unique access to diverse, high potential, growth-ready assets in North America’s emerging cannabis market.